Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novaccess Global Inc XSNX

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.


OTCQB:XSNX - Post by User

Bullboard Posts
Post by capricorn2on Aug 04, 2008 3:55pm
402 Views
Post# 15356637

News!

News!

XsunX Exhibiting at the European Photovoltaic Conference in Valencia Spain
8/4/2008 6:00 AM - PR Newswire

The Company will be Co-located at the State of Oregon Booth

ALISO VIEJO, Calif., Aug 04, 2008 /PRNewswire-FirstCall via COMTEX News Network/ --

XsunX, Inc. (OTC Bulletin Board: XSNX), a solar technology Company engaged in the build-out of its multi-megawatt thin film photovoltaic (TFPV) solar manufacturing facilities, announced today that they will be co-locating with the State of Oregon at booth D 29 located in Hall 3 at the 23rd European Photovoltaic Solar Energy Conference & Exhibition held September 1-4 in Valencia Spain.

This year's international industrial exhibition in Valencia will be the biggest ever held in the area of solar power generation and is the World's largest specialist conference in the Photovoltaic Solar Energy Sector attracting more than 12,000 specialist visitors.

In addition to having a company presence at the exhibition level, Mr. Alan Goodrich of Ibis & Associates' paper featuring XsunX data was selected for a visual Poster presentation from 1322 papers submitted. The paper titled 'The Competitive Cost Position of Novel Thin Film Photovoltaic Module Technologies in High Temperature and Low light Conditions' was reviewed by a committee composed of 70 international PV experts and a team of 30 session organizers. In an email to Mr. Goodrich from the PV Conference 'The Scientific Committee expressed the opinion that the paper should be brought to the attention of the distinguished audience expected at the event."

"We are looking forward to co-locating with the State of Oregon at the World's largest Photovoltaic show," stated Mr. Joe Grimes, COO of XsunX. "We are working towards establishing a corporate presence in the State of Oregon and being a world class Photovoltaic supplier of renewable energy." concluded Grimes.

For more information about XsunX, please visit https://www.XsunX.com

Safe Harbor Statement: Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate", "believe", "estimate", "may", "intend", "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.

SOURCE XsunX, Inc.

https://www.XsunX.com/

Copyright (C) 2008 PR Newswire. All rights reserved

Bullboard Posts